BindingDB logo
myBDB logout

BDBM239907 US9403767, 72::US9403767, 73

SMILES: CN(C)C1(CCC(CC1)(N(C)C)c1ccc(cc1)C(F)(F)F)c1ccccc1

InChI Key: InChIKey=KXSLNFUDGWMNKK-UHFFFAOYSA-N

Data: 4 KI

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 4 hits for monomerid = 239907   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Mu-type opioid receptor


(Homo sapiens (Human))
BDBM239907
PNG
(US9403767, 72 | US9403767, 73)
Show SMILES CN(C)C1(CCC(CC1)(N(C)C)c1ccc(cc1)C(F)(F)F)c1ccccc1 |(-1.65,-6.62,;-.11,-6.57,;-.22,-8.11,;.61,-5.21,;1.94,-4.44,;1.94,-2.9,;.61,-2.13,;-.72,-2.9,;-.72,-4.44,;1.33,-.77,;1.44,.77,;2.87,-.72,;-.11,-.77,;-1.65,-.72,;-2.37,.64,;-1.56,1.95,;-.02,1.9,;.7,.54,;-2.28,3.31,;-3,4.67,;-3.64,2.59,;-.92,4.03,;1.33,-6.57,;2.87,-6.62,;3.6,-7.98,;2.78,-9.29,;1.24,-9.24,;.52,-7.88,)|
Show InChI InChI=1S/C23H29F3N2/c1-27(2)21(18-8-6-5-7-9-18)14-16-22(17-15-21,28(3)4)19-10-12-20(13-11-19)23(24,25)26/h5-13H,14-17H2,1-4H3
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
27 -10.3n/an/an/an/an/an/a25



GRUENENTHAL GMBH

US Patent


Assay Description
The affinity to the human μ-opiate receptor was determined in a homogeneous preparation in microtiter plates. For this, dilution series of the res...


US Patent US9403767 (2016)


BindingDB Entry DOI: 10.7270/Q23R0RSJ
More data for this
Ligand-Target Pair
Nociceptin receptor


(Homo sapiens (Human))
BDBM239907
PNG
(US9403767, 72 | US9403767, 73)
Show SMILES CN(C)C1(CCC(CC1)(N(C)C)c1ccc(cc1)C(F)(F)F)c1ccccc1 |(-1.65,-6.62,;-.11,-6.57,;-.22,-8.11,;.61,-5.21,;1.94,-4.44,;1.94,-2.9,;.61,-2.13,;-.72,-2.9,;-.72,-4.44,;1.33,-.77,;1.44,.77,;2.87,-.72,;-.11,-.77,;-1.65,-.72,;-2.37,.64,;-1.56,1.95,;-.02,1.9,;.7,.54,;-2.28,3.31,;-3,4.67,;-3.64,2.59,;-.92,4.03,;1.33,-6.57,;2.87,-6.62,;3.6,-7.98,;2.78,-9.29,;1.24,-9.24,;.52,-7.88,)|
Show InChI InChI=1S/C23H29F3N2/c1-27(2)21(18-8-6-5-7-9-18)14-16-22(17-15-21,28(3)4)19-10-12-20(13-11-19)23(24,25)26/h5-13H,14-17H2,1-4H3
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
115n/an/an/an/an/an/a7.4n/a



GRUENENTHAL GMBH

US Patent


Assay Description
The compounds were examined with membranes of recombinant CHO-ORL 1 cells in a receptor binding assay with 3H-nociceptin/orphanin FQ. This test syste...


US Patent US9403767 (2016)


BindingDB Entry DOI: 10.7270/Q23R0RSJ
More data for this
Ligand-Target Pair
Nociceptin receptor


(Homo sapiens (Human))
BDBM239907
PNG
(US9403767, 72 | US9403767, 73)
Show SMILES CN(C)C1(CCC(CC1)(N(C)C)c1ccc(cc1)C(F)(F)F)c1ccccc1 |(-1.65,-6.62,;-.11,-6.57,;-.22,-8.11,;.61,-5.21,;1.94,-4.44,;1.94,-2.9,;.61,-2.13,;-.72,-2.9,;-.72,-4.44,;1.33,-.77,;1.44,.77,;2.87,-.72,;-.11,-.77,;-1.65,-.72,;-2.37,.64,;-1.56,1.95,;-.02,1.9,;.7,.54,;-2.28,3.31,;-3,4.67,;-3.64,2.59,;-.92,4.03,;1.33,-6.57,;2.87,-6.62,;3.6,-7.98,;2.78,-9.29,;1.24,-9.24,;.52,-7.88,)|
Show InChI InChI=1S/C23H29F3N2/c1-27(2)21(18-8-6-5-7-9-18)14-16-22(17-15-21,28(3)4)19-10-12-20(13-11-19)23(24,25)26/h5-13H,14-17H2,1-4H3
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
165n/an/an/an/an/an/a7.4n/a



GRUENENTHAL GMBH

US Patent


Assay Description
The compounds were examined with membranes of recombinant CHO-ORL 1 cells in a receptor binding assay with 3H-nociceptin/orphanin FQ. This test syste...


US Patent US9403767 (2016)


BindingDB Entry DOI: 10.7270/Q23R0RSJ
More data for this
Ligand-Target Pair
Mu-type opioid receptor


(Homo sapiens (Human))
BDBM239907
PNG
(US9403767, 72 | US9403767, 73)
Show SMILES CN(C)C1(CCC(CC1)(N(C)C)c1ccc(cc1)C(F)(F)F)c1ccccc1 |(-1.65,-6.62,;-.11,-6.57,;-.22,-8.11,;.61,-5.21,;1.94,-4.44,;1.94,-2.9,;.61,-2.13,;-.72,-2.9,;-.72,-4.44,;1.33,-.77,;1.44,.77,;2.87,-.72,;-.11,-.77,;-1.65,-.72,;-2.37,.64,;-1.56,1.95,;-.02,1.9,;.7,.54,;-2.28,3.31,;-3,4.67,;-3.64,2.59,;-.92,4.03,;1.33,-6.57,;2.87,-6.62,;3.6,-7.98,;2.78,-9.29,;1.24,-9.24,;.52,-7.88,)|
Show InChI InChI=1S/C23H29F3N2/c1-27(2)21(18-8-6-5-7-9-18)14-16-22(17-15-21,28(3)4)19-10-12-20(13-11-19)23(24,25)26/h5-13H,14-17H2,1-4H3
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
1.70E+3 -7.87n/an/an/an/an/an/a25



GRUENENTHAL GMBH

US Patent


Assay Description
The affinity to the human μ-opiate receptor was determined in a homogeneous preparation in microtiter plates. For this, dilution series of the res...


US Patent US9403767 (2016)


BindingDB Entry DOI: 10.7270/Q23R0RSJ
More data for this
Ligand-Target Pair